Cynthia A. Carlson

Cynthia A. Carlson serves as a Contract Specialist at Naval Hospital (N68095), where she plays a pivotal role in executing mission-critical acquisitions that support the delivery of high-integrity medical and surgical care to active-duty personnel, veterans, and their families. She manages a diverse portfolio of procurements aligned with the Department of Defense’s operational health priorities, focusing on clinical equipment, diagnostic technologies, and laboratory infrastructure. Her acquisitions ensure compliance with federal acquisition regulations and support the hospital’s strategic goals of enhancing point-of-care diagnostics and maintaining sterile, high-reliability medical environments. While specific contractor names are not publicly disclosed, Carlson maintains professional relationships with a broad spectrum of vendors specializing in medical technology, including manufacturers of surgical instruments, in-vitro diagnostic substances, and precision measuring devices. She engages with both large-scale defense contractors and niche suppliers capable of meeting stringent military medical standards, fostering partnerships grounded in quality assurance, regulatory compliance, and timely delivery. Carlson’s procurement patterns reflect a strong emphasis on open competition, with 85% of acquisitions conducted without set-asides. However, she consistently allocates 15% of contracting opportunities to total small business set-asides under FAR 19.5, demonstrating a deliberate commitment to small business participation without prioritizing specific socioeconomic categories such as 8(a), HUBZone, or SDVOSB. Her approach balances mission necessity with broad-based vendor access. Her primary NAICS focus includes surgical and medical instrument manufacturing (339112), in-vitro diagnostic substance manufacturing (325413), and related technical services in medical device calibration and laboratory automation. This specialization underscores her technical expertise in procuring FDA-regulated, military-spec medical technologies essential to combat readiness and clinical excellence.